ArticleMolecular therapy oncolytics2022

Cross-study safety analysis of risk factors in CAR T cell clinical trials: An FDA database pilot project.

Matthew Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.